[go: up one dir, main page]

EE04296B1 - Antidepressiivse toimega vahend, mis sisaldab pramipeksooli ja sertraliini - Google Patents

Antidepressiivse toimega vahend, mis sisaldab pramipeksooli ja sertraliini

Info

Publication number
EE04296B1
EE04296B1 EEP200100014A EEP200100014A EE04296B1 EE 04296 B1 EE04296 B1 EE 04296B1 EE P200100014 A EEP200100014 A EE P200100014A EE P200100014 A EEP200100014 A EE P200100014A EE 04296 B1 EE04296 B1 EE 04296B1
Authority
EE
Estonia
Prior art keywords
sertraline
agent containing
antidepressant agent
containing pramipexole
pramipexole
Prior art date
Application number
EEP200100014A
Other languages
English (en)
Inventor
Maj Jerzy
Original Assignee
Boehringer Ingelheim Pharma Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma Kg filed Critical Boehringer Ingelheim Pharma Kg
Publication of EE200100014A publication Critical patent/EE200100014A/et
Publication of EE04296B1 publication Critical patent/EE04296B1/et

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EEP200100014A 1998-07-07 1999-07-02 Antidepressiivse toimega vahend, mis sisaldab pramipeksooli ja sertraliini EE04296B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19830201A DE19830201A1 (de) 1998-07-07 1998-07-07 Mittel mit antidepressiver Wirkung
PCT/EP1999/004595 WO2000002542A2 (de) 1998-07-07 1999-07-02 Mittel mit antidepressiver wirkung, enthaltend pramipexol und ein weiteres antidepressivum

Publications (2)

Publication Number Publication Date
EE200100014A EE200100014A (et) 2002-06-17
EE04296B1 true EE04296B1 (et) 2004-06-15

Family

ID=7873155

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200100014A EE04296B1 (et) 1998-07-07 1999-07-02 Antidepressiivse toimega vahend, mis sisaldab pramipeksooli ja sertraliini

Country Status (32)

Country Link
US (1) US6255329B1 (et)
EP (1) EP1093369B1 (et)
JP (1) JP2002520273A (et)
KR (1) KR100557692B1 (et)
CN (1) CN1230168C (et)
AR (1) AR019896A1 (et)
AT (1) ATE228365T1 (et)
AU (1) AU762128B2 (et)
BG (1) BG64972B1 (et)
BR (1) BR9911768A (et)
CA (1) CA2336833C (et)
CZ (1) CZ294087B6 (et)
DE (2) DE19830201A1 (et)
DK (1) DK1093369T3 (et)
EA (1) EA003142B1 (et)
EE (1) EE04296B1 (et)
ES (1) ES2183583T3 (et)
HU (1) HUP0103922A3 (et)
ID (1) ID27776A (et)
IL (1) IL140603A0 (et)
MY (1) MY117969A (et)
NO (1) NO20010064L (et)
NZ (1) NZ509729A (et)
PL (1) PL195043B1 (et)
PT (1) PT1093369E (et)
RS (1) RS49795B (et)
SK (1) SK284923B6 (et)
TR (1) TR200100146T2 (et)
TW (1) TW592698B (et)
WO (1) WO2000002542A2 (et)
YU (1) YU401A (et)
ZA (1) ZA200100090B (et)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000006162A1 (de) * 1998-07-27 2000-02-10 Boehringer Ingelheim Pharma Kg Mittel mit antidepressiver wirkung, mit pramipexol und einem weiteren antidepressivum
WO2002069974A1 (en) * 2001-03-05 2002-09-12 Andrew Holman Administration of sleep restorative agents
DE10138275A1 (de) * 2001-08-10 2003-02-27 Boehringer Ingelheim Pharma Verbindungen zur Beseitigung der Anhedonie
ES2432527T3 (es) * 2001-12-11 2013-12-04 University Of Virginia Patent Foundation Uso de pramipexol para tratar la esclerosis lateral amiotrófica
US20060281797A1 (en) * 2001-12-11 2006-12-14 University Of Virginia Patent Foundation Neurorestoration with R(+) Pramipexole
DE10334187A1 (de) * 2003-07-26 2005-03-03 Schwarz Pharma Ag Substituierte 2-Aminotetraline zur Behandlung von Depressionen
DE10334188B4 (de) * 2003-07-26 2007-07-05 Schwarz Pharma Ag Verwendung von Rotigotin zur Behandlung von Depressionen
WO2005070428A1 (en) * 2004-01-22 2005-08-04 Boehringer Ingelheim International Gmbh Pharmaceutical composition comprising a monoamine neurotransmitter re-uptake inhibitor and a dopamine agonist
ATE444750T1 (de) * 2005-08-15 2009-10-15 Univ Virginia Neurorestauration mit r(+) pramipexol
US8518926B2 (en) 2006-04-10 2013-08-27 Knopp Neurosciences, Inc. Compositions and methods of using (R)-pramipexole
PL2026803T3 (pl) 2006-05-16 2012-05-31 Knopp Neurosciences Inc Kompozycje R(+) i S(-) pramipeksolu i sposoby ich zastosowania
US20080254118A1 (en) * 2007-04-11 2008-10-16 Hans-Werner Wernersbach Process for preparing pramipexole dihydrochloride tablets
US8524695B2 (en) 2006-12-14 2013-09-03 Knopp Neurosciences, Inc. Modified release formulations of (6R)-4,5,6,7-tetrahydro-N6-propyl-2,6-benzothiazole-diamine and methods of using the same
JP2010521496A (ja) 2007-03-14 2010-06-24 ノップ ニューロサイエンシーズ、インク． キラル精製置換ベンゾチアゾールジアミンの合成
US20080254117A1 (en) * 2007-04-10 2008-10-16 Noel Cotton Process for preparing pramipexole dihydrochloride tablets
CA2734491A1 (en) * 2008-08-19 2010-02-25 Knopp Neurosciences, Inc. Compositions and methods of using (r)-pramipexole
US20100069390A1 (en) 2008-09-05 2010-03-18 Supernus Pharmaceuticals, Inc. Method of treatment of attention deficit/hyperactivity disorder (ADHD)
MX2011011579A (es) * 2009-04-30 2012-01-27 Supernus Pharmaceuticals Inc Metodo de tratamiento contra la depresion.
US9512096B2 (en) 2011-12-22 2016-12-06 Knopp Biosciences, LLP Synthesis of amine substituted 4,5,6,7-tetrahydrobenzothiazole compounds
ES2950875T3 (es) 2012-02-08 2023-10-16 Supernus Pharmaceuticals Inc Formulaciones de liberación modificada de viloxazina
US9662313B2 (en) 2013-02-28 2017-05-30 Knopp Biosciences Llc Compositions and methods for treating amyotrophic lateral sclerosis in responders
US9468630B2 (en) 2013-07-12 2016-10-18 Knopp Biosciences Llc Compositions and methods for treating conditions related to increased eosinophils
WO2015006708A1 (en) 2013-07-12 2015-01-15 Knopp Biosciences Llc Treating elevated levels of eosinophils and/or basophils
EP3038467B1 (en) 2013-08-13 2020-07-29 Knopp Biosciences LLC Compositions and methods for treating plasma cell disorders and b-cell prolymphocytic disorders
ES2871556T3 (es) 2013-08-13 2021-10-29 Knopp Biosciences Llc Composiciones y métodos para el tratamiento de la urticaria crónica
IL312486B2 (en) * 2017-04-10 2025-05-01 Chase Therapeutics Corp NK1 antagonist combination and method for treating synucleinopathies
US11266633B2 (en) 2017-06-30 2022-03-08 Chase Therapeutics Corporation NK-1 antagonist compositions and methods for use in treating depression
CN110028464B (zh) * 2019-04-26 2022-11-18 浙江海洋大学 一种南极真菌次级代谢衍生物BTZ-one及其制备方法和应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4536518A (en) * 1979-11-01 1985-08-20 Pfizer Inc. Antidepressant derivatives of cis-4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine
DE3572485D1 (en) * 1984-12-22 1989-09-28 Thomae Gmbh Dr K Tetrahydro-benzothiazoles, their production and their use as intermediates or drugs
DE3843227A1 (de) * 1988-12-22 1990-07-05 Boehringer Ingelheim Kg Neue verwendung von 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzthiazol
US4962128A (en) * 1989-11-02 1990-10-09 Pfizer Inc. Method of treating anxiety-related disorders using sertraline
DE3937271A1 (de) * 1989-11-09 1991-05-16 Boehringer Ingelheim Kg Transdermale applikation von 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzothiazol
US5248699A (en) * 1992-08-13 1993-09-28 Pfizer Inc. Sertraline polymorph
DE4241013A1 (de) * 1992-12-05 1994-06-09 Boehringer Ingelheim Kg Verwendung von 2-Amino-6-n-propyl-amino-4,5,6,7-tetrahydrobenzothiazol als Arzneimittel mit antidepressiver Wirkung
JP3947582B2 (ja) * 1995-08-15 2007-07-25 中外製薬株式会社 不安神経症治療剤
ATE302182T1 (de) * 1996-03-29 2005-09-15 Pfizer Benkyl(idene)-lactam-derivate, deren herstellung und verwendung als selektive (ant)agonisten von 5-ht1a- und/oder 5-ht1d rezeptoren
JP2001507678A (ja) * 1996-12-02 2001-06-12 メルク シヤープ エンド ドーム リミテツド 運動障害の治療のためのｎｋ−１受容体拮抗薬の使用
CA2318095C (en) * 1998-01-13 2012-11-20 Barry S. Fogel Methods of treating tardive dyskinesia and other movement disorders

Also Published As

Publication number Publication date
NO20010064D0 (no) 2001-01-05
ATE228365T1 (de) 2002-12-15
PL345842A1 (en) 2002-01-14
NZ509729A (en) 2003-06-30
CN1308533A (zh) 2001-08-15
PT1093369E (pt) 2003-03-31
CZ294087B6 (cs) 2004-10-13
PL195043B1 (pl) 2007-08-31
ES2183583T3 (es) 2003-03-16
CA2336833C (en) 2008-09-23
NO20010064L (no) 2001-03-02
KR100557692B1 (ko) 2006-03-07
AU762128B2 (en) 2003-06-19
MY117969A (en) 2004-08-30
TR200100146T2 (tr) 2001-07-23
EA003142B1 (ru) 2003-02-27
WO2000002542A2 (de) 2000-01-20
DE19830201A1 (de) 2000-01-13
HUP0103922A3 (en) 2002-08-28
EE200100014A (et) 2002-06-17
EP1093369B1 (de) 2002-11-27
DK1093369T3 (da) 2002-12-16
BR9911768A (pt) 2001-04-03
US6255329B1 (en) 2001-07-03
RS49795B (sr) 2008-06-05
EP1093369A2 (de) 2001-04-25
HUP0103922A2 (hu) 2002-03-28
HK1037976A1 (en) 2002-03-01
ID27776A (id) 2001-04-26
WO2000002542A3 (de) 2000-06-22
AU5030399A (en) 2000-02-01
CN1230168C (zh) 2005-12-07
TW592698B (en) 2004-06-21
EA200100084A1 (ru) 2001-08-27
ZA200100090B (en) 2002-04-04
JP2002520273A (ja) 2002-07-09
BG64972B1 (bg) 2006-11-30
CA2336833A1 (en) 2000-01-20
YU401A (sh) 2003-10-31
BG105112A (bg) 2001-10-31
SK284923B6 (sk) 2006-02-02
DE59903556D1 (de) 2003-01-09
CZ200177A3 (en) 2001-06-13
SK112001A3 (en) 2001-10-08
IL140603A0 (en) 2002-02-10
AR019896A1 (es) 2002-03-20
KR20010079491A (ko) 2001-08-22

Similar Documents

Publication Publication Date Title
EE04296B1 (et) Antidepressiivse toimega vahend, mis sisaldab pramipeksooli ja sertraliini
ID28787A (id) 2-fenilbenzimidazol tersubstitusi, pembuatannya dan penggunaannya
EE200000766A (et) Ravimkoostis, mis sisaldab COX-2 inhibiitorit ja iNOS inhibiitorit
ID30393A (id) Senyawa tienopirimidina, pembuatan dan penggunaannya
MA26866A1 (fr) Agents antibacteriens consistant en 3-aminoquinazoline-2,4-diones
NO20005503L (no) Ny anvendelse
ID22957A (id) Senyawa dan penggunaannya
DE69929047D1 (de) Haarbehandlungsmittel
DE69919970D1 (de) Axiallüfter
NL1016224A1 (nl) Foto-basevormend middel en foto-zuurvormend middel bevattende foto- etssamenstelling.
DE69822124D1 (de) Axiallüfter
ID27922A (id) KOMPOSISI FARMASETIKAL DAN PENGGUNAAN DARI ANDROST-5-ENA-3β, 17β-DIOL
DK1112003T3 (da) Ny sammensætning og anvendelse
DE69921931D1 (de) Axiallüfter
NO20001847D0 (no) Ny anvendelse av forbindelser for anti-kløe-aktivitet
IS5951A (is) 5HT1 mótlyf fyrir meðferð gegn þunglyndi
DZ2547A1 (fr) Formes posologiques de sertraline à libération prolongée.
NO20010654L (no) Ny anvendelse av taxoidderivater
TR199903132A3 (tr) Metalosan bilesiklerinin aktive edici kompozisyonu.
MA26666A1 (fr) Antioxide, composition antiproliferee, y compris carnitine et carotenoide.
PT941081E (pt) Nova utilizacao de creatina
NO20005483L (no) Ny sammensetning
ID26780A (id) Senyawa-senyawa tienopiridina, hasil dan kegunaannya
IL162014A0 (en) Shape-recovering material suitable for application of an attachment, and its use
SI1093369T1 (sl) Sredstvo z antidepresivnim učinkom, ki obsega pramipeksol in sertralin

Legal Events

Date Code Title Description
HC1A Change of owner name
KB4A Valid patent at the end of a year

Effective date: 20041231

KB4A Valid patent at the end of a year

Effective date: 20051231

KB4A Valid patent at the end of a year

Effective date: 20061231

KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

MM4A Lapsed by not paying the annual fees

Effective date: 20090702